UK medical cannabis clinic Releaf has launched a new 24/7 on-demand legal support service for its prescribed patients, helping navigate
In this special edition of the Business of Cannabis Podcast, Tim Kirby, CEO of Releaf, sits down with Professor Chris Shambrook, renowned performance psychologist and long-time advisor to the British Olympic rowing team.
The third in our series of guest episodes features a discussion between the CEO of Releaf, Tim Kirby, and Robert Jappie, a partner at Fieldfisher LLP specialising in regulatory law.
With Germany recently making some foundational changes to its medical cannabis framework, helping expand access significantly and driving a surge in patient numbers, we spoke to leading UK-based clinic Releaf to understand what structural, cultural, and clinical lessons the UK can learn from Germany’s success.
The second in our series of guest episodes features a discussion between CEO of Releaf, Tim Kirby, and James Duckenfield,
Creating a culture that focuses on the behaviours required to achieve the results desired, has been the root cause of Releaf’s success in the UK’s medical cannabis sector – a sector that has stagnated since medical cannabis became legal in 2018.
Since the UK legalisation of CBPMs in 2018, the sector has faced slow adoption due to ineffective patient outreach, inconsistent supply chains and variable quality control from other providers.
We won’t spam you
